Monitor the outcome of the annual meeting on July 31, 2026 for any unexpected voting results, though all proposals are expected to pass given board recommendations. No immediate trading action warranted.
Price Chart
Executive Summary
Jasper Therapeutics filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled for July 31, 2026. The meeting will include election of two Class II directors, ratification of PricewaterhouseCoopers as auditor, and an advisory vote on executive compensation. The board recommends a vote FOR all proposals. This is a routine proxy solicitation with no material financial impact.
Key Financial Metrics
Key Facts
- Annual Meeting to be held virtually on July 31, 2026 at 10:00 a.m. Pacific Time.
- Proposals include election of two Class II directors, ratification of auditor, and advisory vote on executive compensation.
- Board recommends FOR all proposals.
- Proxy materials available online; paper copies can be requested by July 17, 2026.
Financial Impact
No financial impact from this routine proxy filing.
Risk Factors
- Low risk of shareholder dissent on say-on-pay vote.
- Minimal risk of director election failure given board recommendations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-068767 |
| Document: 0001213900-26-068767-index-headers.html | 0001213900-26-068767 |
| Document: 0001213900-26-068767-index.html | 0001213900-26-068767 |
| Document: 0001213900-26-068767.txt | 0001213900-26-068767 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | SC TO-I/A | $0.5054 | awaiting T+5 | — | $0.5190 (+2.69%) |
Oct 20, 2026 7d ago | DEF 14A | $0.4999 $0.5189 | ▲ +3.80% | ▲ +3.72% | $0.5190 (+3.82%) |
Oct 15, 2026 12d ago | 8-K | $0.5321 $0.4956 | ▼ −6.86% | ▼ −5.85% | $0.5190 (−2.46%) |
Oct 15, 2026 12d ago | Press Release | $0.5320 $0.4960 | ▲ +6.77% | ▲ +5.75% | $0.5190 (+2.44%) |
Oct 14, 2026 13d ago | S-3 | $0.5321 $0.4956 | ▲ +6.86% | ▲ +5.85% | $0.5190 (+2.46%) |
Oct 7, 2026 20d ago | 8-K | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5190 (−8.90%) |
Oct 7, 2026 20d ago | SC TO-I | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5190 (−8.90%) |
Sep 24, 2026 4w ago | 25-NSE | $0.6091 $0.5652 | ▲ +7.21% | ▲ +6.99% | $0.5190 (+14.79%) |
Aug 14, 2026 10w ago | Press Release | $0.7901 $0.7160 | ▼ −9.38% | ▼ −8.01% | $0.5190 (−34.31%) |
Jul 31, 2026 12w ago | 8-K | $0.6300 $0.7095 | ▲ +12.62% | ▲ +9.11% | $0.5190 (−17.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers